[Effect of electroacupuncture combined with medication on vascular endothelial cells in the compound hypertension and hyperlipemia rat]

Zhongguo Zhen Jiu. 2006 Dec;26(12):875-8.
[Article in Chinese]

Abstract

Objective: To explore the mechanism of electroacupuncture combined with medication for treatment of compound model of hypertension and hyperlipemia (CMHH).

Methods: CMHH rat model was made by the way of "2K1C" combined with intragastric perfusion of high fat diet, and a normal group and a pseudosurgery group were set up. After modeling for 4 weeks, the successful model rats who had synchronously increase of blood pressure (BP) and blood lipids were randomly divided into a model group, a medication group , an electroacupuncture group and an acupuncture plus medication group. After interference of 4 weeks, changes of BP, total cholesterol (TC) and thiglyceride (TG) and contents of serum vWF, tissue plasminogen activator (t-PA ) and plasminogen activator inhibitor-1 (PAl-1) were observed.

Results: After interference, the levels of BP, TC, TG, vWF, t-PA and PAl-1 significantly changed in all the treatment groups as compared with those in the model group (P < 0.05 or P < 0.01) with most significantly changed in the electroacupuncture plus medication group.

Conclusion: Both electroacupunctore and electroacupuncture combined with medication can down-regulate levels of BP, TC, TG, and decrease plasma vWF and PAl-1 levels, increase t-PA content, so as to effectively prevent and treat CMHH and possibly induced cerebral diseases.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cholesterol / blood
  • Electroacupuncture*
  • Endothelial Cells / physiology*
  • Female
  • Hyperlipidemias / blood
  • Hyperlipidemias / therapy*
  • Hypertension / blood
  • Hypertension / therapy*
  • Male
  • Plasminogen Activator Inhibitor 1 / blood
  • Rats
  • Rats, Wistar
  • Tissue Plasminogen Activator / blood
  • Triglycerides / blood
  • von Willebrand Factor / analysis

Substances

  • Plasminogen Activator Inhibitor 1
  • Triglycerides
  • von Willebrand Factor
  • Cholesterol
  • Tissue Plasminogen Activator